Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
James Brown, Kartik Kumar, Jacob Reading, Jennifer Harvey, Saraswathi Murthy, Santino Capocci, Susan Hopkins, Suranjith Seneviratne, Ian Cropley, Marc Lipman. Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results. Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017

Member's Comments

No comment yet.

Related content which might interest you: Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Discordance QuantiFERON-TB Gold in-tube and tuberculin skin test: Latent tuberculosis infection or immunological memory? Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 QuantiFERON®-TB or QFT in sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Importance of QuantiFERON-TB Gold and tuberculin skin test in the differential diagnosis of active and inactive pulmonary tuberculosis Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 133s Year: 2007 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Value of QFT-IT test for diagnosing latent TB infection in HIV+ Source: ISSN=ISSN 1810-6838, ISBN=, page=284 Year: 2007 The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Tuberculosis after a borderline QuantiFERON result during screening before infliximab Source: Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018 Year: 2018